Company Overview

Update
Founders:
Andras Forgacs
Headquarters:
San Diego, CA
IPO:
Went Public on Feb 24, 2012
Stock:
NYSEMKT:ONVO
Categories:
Biotechnology
Description:
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Detailed Description

Update

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Current Team (3)

Update

Past Team (1)

Update

Funding Rounds (3) - $26.4M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    6275 Nancy Ridge Drive

    Suite 110

    San Diego, CA 92121

    USA

Competitors (1)

Update

Images (1)

Update
  • Fcbd3bfddc05261e40302863a34ad012